Skip to main content
TipRanks
Go Ultimate75% OFF

Medius Holdings Co., Ltd. (3154) AI Stock Analysis

1 Followers
JP:3154

Medius Holdings Co., Ltd.

(TSE/TYO:3154)

Select Model
Rating:41Neutral
Price Target:JPY 690.00â–¼(-4.56% Downside)
Action:upgraded
Date:11/18/26

The overall score is very low, driven primarily by severe financial distress. The collapse in operating cash flow to near zero and negative free cash flow is a critical risk. This is compounded by a bearish technical trend with the stock trading below all major moving averages. While the balance sheet leverage has improved and the dividend yield offers some support, these factors are insufficient to offset the fundamental deterioration in profitability and liquidity.

Positive Factors
Steady Revenue ExpansionSustained revenue expansion indicates continuing demand for the company’s medical-device distribution activities and supports a durable operating base. A recovery from the 2022 decline also suggests the business has regained scale, although future benefits depend on converting sales into stronger earnings and cash.
Negative Factors
Volatile Cash GenerationUnstable cash conversion reduces confidence that reported earnings consistently fund the business. Negative free cash flow can increase reliance on working-capital management or external financing, while the recurring historical volatility makes liquidity execution a material concern over the next several quarters.

Medius Holdings Co., Ltd. (3154) vs. iShares MSCI Japan ETF (EWJ)

-10%0%10%20%30%JP:3154-6.11%EWJ+16.16%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 15.97B
Dividend Yield
2.77%
Average Volume (3M)
26.02K
Price to Earnings (P/E)
15.2
Beta (1Y)
0.58
Revenue Growth
5.05%
EPS Growth
-24.77%
Country
Japan
Employees
2,716
Sector
Healthcare
Sector Strength
51
Industry
Medical - Distribution

Medius Holdings Co., Ltd. Business Overview & Revenue Model

Company Description

Medius Holdings Co., Ltd. is a Japanese enterprise deeply embedded in the healthcare sector. The company's operations involve the distribution of a diverse range of medical devices, encompassing fundamental consumables such as syringes and gauze, as...

How the Company Makes Money

Medius Holdings primarily makes money through the sale and distribution of medical devices and related medical consumables to healthcare providers (e.g., hospitals and clinics). Revenue is generated when the company procures products from manufacture...

Medius Holdings Co., Ltd. Financial Statement Overview

Summary

Financial performance is weak. While revenue grew 4.7%, net income fell 31% with margins below 0.5%. Operating cash flow collapsed to ¥374M, resulting in negative free cash flow and a 0.46% coverage ratio. The improved balance sheet leverage is the only positive, but it is overshadowed by severe profitability and cash flow deterioration.

Income Statement

28Negative

Balance Sheet

62Positive

Cash Flow

22Negative
Financial statement breakdown
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue306.44B302.34B288.69B259.79B239.05B221.69B
Gross Profit35.59B35.82B33.30B31.09B29.31B27.42B
EBITDA4.34B4.01B4.77B3.86B4.27B3.80B
Net Income1.06B944.09M1.38B1.12B1.50B1.87B
Balance Sheet
Total Assets117.60B112.59B113.54B115.34B97.73B93.15B
Cash, Cash Equivalents and Short-Term Investments10.91B10.05B14.33B13.64B10.33B9.11B
Total Debt23.93B18.39B21.89B24.57B19.70B17.98B
Total Liabilities96.91B91.85B93.06B95.60B79.15B75.84B
Stockholders Equity20.67B20.74B20.48B19.74B18.57B17.31B
Cash Flow
Free Cash Flow0-373.71M5.26B261.12M300.65M-8.49B
Operating Cash Flow0374.23M7.01B1.92B1.22B-3.90B
Investing Cash Flow0-1.26B-2.51B-2.67B-862.94M-4.82B
Financing Cash Flow0-3.40B-3.47B4.01B862.90M5.21B

Medius Holdings Co., Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price723.00

Price Trends

50DMA762.82Negative
100DMA780.17Negative
200DMA794.04Negative

Market Momentum

MACD-14.02Negative
RSI39.61Neutral
STOCH54.02Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3154, the sentiment is Negative. The current price of 723.00 is below the 20-day moving average (MA) of 734.55, below the 50-day MA of 762.82, and below the 200-day MA of 794.04, indicating a bearish trend. The MACD of -14.02 indicates Negative momentum. The RSI at 39.61 is Neutral, neither overbought nor oversold. The STOCH value of 54.02 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3154.

Medius Holdings Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

JP:3154 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:7730JP:773079OutperformJPY 150.93B20.85―2.68%10.18%55.86%
JP:7747JP:774772OutperformJPY 1.11T31.1621.31%1.15%22.57%138.10%
JP:7979JP:797966NeutralJPY 79.22B12.68―3.51%8.74%36.76%
JP:7716JP:771660NeutralJPY 272.90B64.053.33%1.88%17.25%-40.40%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
JP:7702JP:770246NeutralJPY 10.43B-12.25―3.98%-3.10%-645.12%
JP:3154JP:315441NeutralJPY 16.08B15.16―2.77%5.05%-24.77%

* Healthcare Sector Average

Performance Comparison

0%20%40%60%JP:3154JP:7747JP:7716JP:7702JP:7730JP:7979Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:3154 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:3154Medius Holdings Co., Ltd.723.00-48.01-6.23%
JP:7747Asahi Intecc Co 4179.001499.6555.97%
JP:7716Nakanishi 1545.00531.6152.46%
JP:7702JMS Co., Ltd.427.0017.814.35%
JP:7730Mani, Inc.1532.00173.7612.79%
JP:7979Shofu Inc.2220.00449.5825.39%

Medius Holdings Co., Ltd. Corporate Events

Medius Holdings Reports Strong First-Quarter Profit Growth

Nov 9, 2026

Medius Holdings Co., Ltd., listed on the Tokyo Stock Exchange’s Prime Market, reported consolidated net sales of ¥76.273 billion for the quarter ended September 30, 2026. The release does not specify the company’s industry, primary products, or servi...

Medius Holdings Issues Correction to First-Quarter Results

Nov 9, 2026

Medius Holdings Co., Ltd., listed on the Tokyo Stock Exchange’s Prime Market, announced a correction to its consolidated financial results for the first quarter ended September 30, 2025. The company said certain items in its previously disclosed resu...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 17, 2026